Literature DB >> 11427277

Protection of rainbow trout against infectious hematopoietic necrosis virus four days after specific or semi-specific DNA vaccination.

S E LaPatra1, S Corbeil, G R Jones, W D Shewmaker, N Lorenzen, E D Anderson, G Kurath.   

Abstract

A DNA vaccine against a fish rhabdovirus, infectious hematopoietic necrosis virus (IHNV), was shown to provide significant protection as soon as 4 d after intramuscular vaccination in 2 g rainbow trout (Oncorhynchus mykiss) held at 15 degrees C. Nearly complete protection was also observed at later time points (7, 14, and 28 d) using a standardized waterborne challenge model. In a test of the specificity of this early protection, immunization of rainbow trout with a DNA vaccine against another fish rhabdovirus, viral hemorrhagic septicemia virus, provided a significant level of cross-protection against IHNV challenge for a transient period of time, whereas a rabies virus DNA vaccine was not protective. This indication of distinct early and late protective mechanisms was not dependent on DNA vaccine doses from 0.1 to 2.5 microg.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11427277     DOI: 10.1016/s0264-410x(01)00113-x

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  17 in total

Review 1.  Fish can be first--advances in fish transgenesis for commercial applications.

Authors:  Halina M Zbikowska
Journal:  Transgenic Res       Date:  2003-08       Impact factor: 2.788

2.  Analysis of DNA-vaccinated fish reveals viral antigen in muscle, kidney and thymus, and transient histopathologic changes.

Authors:  Kyle A Garver; Carla M Conway; Diane G Elliott; Gael Kurath
Journal:  Mar Biotechnol (NY)       Date:  2005-07-22       Impact factor: 3.619

3.  Introduction of translation stop codons into the viral glycoprotein gene in a fish DNA vaccine eliminates induction of protective immunity.

Authors:  Kyle A Garver; Carla M Conway; Gael Kurath
Journal:  Mar Biotechnol (NY)       Date:  2006-06-12       Impact factor: 3.619

4.  Inhibition of an Aquatic Rhabdovirus Demonstrates Promise of a Broad-Spectrum Antiviral for Use in Aquaculture.

Authors:  Bethany F Balmer; Rachel L Powers; Ting-Hu Zhang; Jihye Lee; Frederic Vigant; Benhur Lee; Michael E Jung; Maureen K Purcell; Kevin Snekvik; Hector C Aguilar
Journal:  J Virol       Date:  2017-01-31       Impact factor: 5.103

5.  CpG DNA induces protective antiviral immune responses in Atlantic salmon (Salmo salar L.).

Authors:  Jorunn B Jørgensen; Lill-Heidi Johansen; Kari Steiro; Audny Johansen
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

6.  Characterization of European sea bass transcripts by RNA SEQ after oral vaccine against V. anguillarum.

Authors:  E Sarropoulou; J Galindo-Villegas; A García-Alcázar; P Kasapidis; V Mulero
Journal:  Mar Biotechnol (NY)       Date:  2012-07-13       Impact factor: 3.619

7.  Towards a metalloprotease-DNA vaccine against piscine cryptobiosis caused by Cryptobia salmositica.

Authors:  Chung-Wei Tan; Palmy Jesudhasan; Patrick T K Woo
Journal:  Parasitol Res       Date:  2007-10-12       Impact factor: 2.289

8.  Immune Efficacy of a Genetically Engineered Vaccine against Lymphocystis Disease Virus: Analysis of Different Immunization Strategies.

Authors:  Fengrong Zheng; Xiuqin Sun; Xing'an Wu; Hongzhan Liu; Jiye Li; Suqi Wu; Jinxing Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2011-07-19       Impact factor: 2.629

Review 9.  Immunity to fish rhabdoviruses.

Authors:  Maureen K Purcell; Kerry J Laing; James R Winton
Journal:  Viruses       Date:  2012-01-18       Impact factor: 5.048

10.  Association mapping of disease resistance traits in rainbow trout using restriction site associated DNA sequencing.

Authors:  Nathan R Campbell; Scott E LaPatra; Ken Overturf; Richard Towner; Shawn R Narum
Journal:  G3 (Bethesda)       Date:  2014-10-28       Impact factor: 3.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.